Novo Nordisk A S (NVO)

Sector:Health Care
Super Investor Stats:
Ownership count:5
Ownership rank:157
% of all portfolios:0.034%
Hold Price * :$36.75
History Portfolio Manager Activity Share change % change to portfolio
Q1  2026
Sarah Ketterer - Causeway Capital Management Add 18.15% 180,363 0.08
Lee Ainslie - Maverick Capital Buy 2,080,121 0.89
Dodge & Cox Funds Buy 19,333,750 0.39
Q4  2025
Sarah Ketterer - Causeway Capital Management Add 42.80% 297,871 0.21
Thomas Gayner - Markel Group Add 21.16% 501,125 0.20
Q3  2025
Sarah Ketterer - Causeway Capital Management Add 96.67% 342,095 0.25
Thomas Gayner - Markel Group Add 4.87% 110,061 0.05
Q2  2025
Thomas Gayner - Markel Group Add 5.05% 108,588 0.06
Sarah Ketterer - Causeway Capital Management Buy 353,884 0.39
Q2  2024
Lee Ainslie - Maverick Capital Add 272.87% 5,744 0.01
Q1  2024
Lee Ainslie - Maverick Capital Buy 2,105 0.01
Q4  2023
Polen Capital Management Add 0.66% 52,189 0.01
Q3  2023
Polen Capital Management Buy 7,906,255 1.89
Q2  2023
Chase Coleman - Tiger Global Management Buy 1,269,000 0.86
Q3  2022
Lee Ainslie - Maverick Capital Buy 4,950 0.01
Q3  2020
Francois Rochon - Giverny Capital Buy 12,400 0.04
Lee Ainslie - Maverick Capital Buy 17,866 0.01
Q4  2019
Polen Capital Management Add 71.82% 99,320 0.01
Q3  2019
Polen Capital Management Add 16.52% 19,612 0.00
Q2  2019
Polen Capital Management Add 29.13% 26,776 0.00
Q2  2012
Thomas Gayner - Markel Group Add 0.84% 19,000 0.01
Q1  2010
Thomas Gayner - Markel Group Add 39.04% 650,000 0.31
Q4  2009
Thomas Gayner - Markel Group Buy 1,665,000 0.75

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.